Medisearch Laboratories (Bombay) Profile
Key Indicators
- Authorised Capital ₹ 1.10 Cr
as on 29-07-2024
- Paid Up Capital ₹ 1.08 Cr
as on 29-07-2024
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.77 Cr
as on 29-07-2024
- Revenue 28.94%
(FY 2023)
- Profit 946.56%
(FY 2023)
- Ebitda 311.23%
(FY 2023)
- Net Worth 22.27%
(FY 2023)
- Total Assets 6.52%
(FY 2023)
About Medisearch Laboratories (Bombay)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 Cr and a paid-up capital of Rs 1.08 Cr.
The company currently has active open charges totaling ₹1.77 Cr.
The Key Managerial Personnel (KMP) at Medisearch Laboratories (Bombay) Private Limited India is Rita Masurkar as CEO. Kishore Masurkar, Mayur Dukare, Nitesh Jadhav, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1985PTC037726
- Company No.
037726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medisearch Laboratories (Bombay)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rita Masurkar | CEO | 30-Oct-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayur Dukare  | Director | 15-Jan-2022 | Current |
| Kishore Masurkar | Director | 11-Oct-1985 | Current |
| Nitesh Jadhav | Director | 14-Apr-2022 | Current |
| Hasmukh Patel | Additional Director | 25-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Medisearch Laboratories (Bombay).
Medisearch Laboratories (Bombay) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.94% increase. The company also saw a substantial improvement in profitability, with a 946.56% increase in profit. The company's net worth Soared by an impressive increase of 22.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisearch Laboratories (Bombay)?
In 2023, Medisearch Laboratories (Bombay) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Mar 2019 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 07 Jun 2000 | ₹7.70 M | Open |
How Many Employees Work at Medisearch Laboratories (Bombay)?
Unlock and access historical data on people associated with Medisearch Laboratories (Bombay), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisearch Laboratories (Bombay), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisearch Laboratories (Bombay)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
